Header Logo

Connection

Doris Benbrook to Annexin A5

Back to Details
This is a "connection" page, showing publications Doris Benbrook has written about Annexin A5.
Doris Benbrook
Connection Strength
0.037
Annexin A5
  1. Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer. Cancer Lett. 2018 07 01; 425:174-182.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.